RICHARD D. KOPKE, M.D.
Medical Practice at 56 St, Oklahoma City, OK
License number
Oklahoma 23693
Category
Medical Practice
Type
Otology & Neurotology
Address
Address
3400 NW 56Th St, Oklahoma City, OK 73112
Phone
(405) 946-5563
(405) 947-6226 (Fax)
(405) 947-6226 (Fax)
Organization information
See more information about RICHARD D. KOPKE at bizstanding.comRICHARD D KOPKE, MD
3400 NW 56 St, Oklahoma City, OK 73112
Phone:
(405) 946-5563 (Phone)
MD:
Richard Kopke (MD)
SIC6:
8011
Otologic Medical Clinic Inc - Richard D Kopke MD
3400 NW 56 St, Oklahoma City, OK 73112
Categories:
Otolaryngology Physicians & Surgeons, Physicians & Surgeons
Phone:
(405) 212-4370 (Phone)
Professional information
Dr. Richard D Kopke, Oklahoma City OK - MD (Doctor of Medicine)
Specialties:
Neurotology
Address:
Otologic Medical Clinic, Inc.
3400 NW 56Th St, Oklahoma City 73112
(405) 946-5563 (Phone)
3400 NW 56Th St, Oklahoma City 73112
(405) 946-5563 (Phone)
Certifications:
Neurotology, 2004, Otolaryngology, 1990
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese, Spanish, Thai
Hospitals:
Otologic Medical Clinic, Inc.
3400 NW 56Th St, Oklahoma City 73112
Integris Baptist Medical Center
3300 North Expressway West, Oklahoma City 73112
3400 NW 56Th St, Oklahoma City 73112
Integris Baptist Medical Center
3300 North Expressway West, Oklahoma City 73112
Education:
Medical School
University Of Washington School Of Medicine
Graduated: 1981
Walter Reed Army Med Center
Graduated: 1982
Tripler Army Med Center
Graduated: 1990
Belfer Institute For Advanced Biomedical Research Albert Einstein College Of Med
Graduated: 1996
Montefiore Med Center Albert Einstein College Of Med
University Of Washington School Of Medicine
Graduated: 1981
Walter Reed Army Med Center
Graduated: 1982
Tripler Army Med Center
Graduated: 1990
Belfer Institute For Advanced Biomedical Research Albert Einstein College Of Med
Graduated: 1996
Montefiore Med Center Albert Einstein College Of Med
Richard Dana Kopke, Oklahoma City OK
Specialties:
Ear, Nose & Throat Doctor
Address:
3400 Nw 56Th St, Oklahoma City, OK 73112
Education:
University of Washington, School of Medicine - Doctor of Medicine
Montefiore Medical Center - Fellowship - Otolaryngical Neurological Skull Surgery
Tripler Army Medical Center - Residency - Otolaryngology
Walter Reed Army Medical Center - Internship - Surgery
Montefiore Medical Center - Fellowship - Otolaryngical Neurological Skull Surgery
Tripler Army Medical Center - Residency - Otolaryngology
Walter Reed Army Medical Center - Internship - Surgery
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology, American Board of Otolaryngology Sub-certificate in Neurotology (Otolaryngology)
Ceo At Hough Ear Institute
Position:
CEO at Hough Ear Institute
Location:
Oklahoma City, Oklahoma Area
Industry:
Research
Work:
Hough Ear Institute
-
CEO
Delivery Of Bioactive Substances To Target Cells
US Patent:
7723311, May 25, 2010
Filed:
Jun 18, 2004
Appl. No.:
10/871243
Inventors:
Charles E. Seeney - Edmond OK, US
Kenneth J. Dormer - Edmond OK, US
Richard D. Kopke - Oklahoma City OK, US
Kenneth J. Dormer - Edmond OK, US
Richard D. Kopke - Oklahoma City OK, US
Assignee:
The United States of America as represented by the Secretary of the Navy - Washington DC
International Classification:
A01N 43/04, A61B 5/055, A01N 25/26, A61F 2/00, C12N 15/00
US Classification:
514 44R, 424 9323, 424417, 424428, 435455
Abstract:
A system for introducing a bioactive substance into a target cell within a body. The bioactive substance is transported to the target cell using a superparamagnetic nanoparticle and a controllable magnetic field generator that is capable of moving the nanoparticle to the target cell through the body in three dimensions. The nanoparticle may be covered with a biocompatible shell that forms a covalent bond with the bioactive substance. In an alternative embodiment, the bioactive substance and a plurality of nanoparticles are supported by a bioerodable matrix that forms a nanosphere. The nanosphere may be moved into the target cell using an external magnetic field that is controllable to move the nanosphere in three dimensions through the body and the bioactive substance is released from the nanosphere once inside the target cell.
Methods For Treating Acute Acoustic Trauma
US Patent:
2012017, Jul 5, 2012
Filed:
Aug 24, 2010
Appl. No.:
13/391772
Inventors:
Richard Dana Kopke - Oklahoma City OK, US
Robert A. Floyd - Oklahoma City OK, US
Robert A. Floyd - Oklahoma City OK, US
International Classification:
A61K 31/205, A61K 31/198, A61P 27/16, A61K 31/185
US Classification:
514556, 514576, 514562
Abstract:
The current invention provides methods and compositions for treating sensorineural hearing loss including but not limited to acute acoustic trauma (AAT). The composition 2,4-disulfonyl α-phenyl tertiary butyl nitrone and N-acetylcysteine (NAC). Preferably, the compositions for treating AAT will be administered orally. However, other methods which deliver the compositions for treating AAT systemically to the body should work equally well.
Composition And Method For Inner Ear Sensory Hair Cell Regeneration And Replacement
US Patent:
2013021, Aug 15, 2013
Filed:
Jun 2, 2011
Appl. No.:
13/701550
Inventors:
Richard D. Kopke - Oklahoma City OK, US
International Classification:
A61K 31/713
US Classification:
514 44 A
Abstract:
A composition and method for replacement and regeneration of hair cells of the inner ear is provided. The composition comprises an active agent in an amount effective to decrease Hes1 gene expression in a tissue of the inner ear. The active agent can be short interfering RNA (siRNA) molecules encapsulated in a biodegradable nanoparticle. The method involves administering a solution to the inner ear where the solution contains an active agent in an amount effective to decrease Hes1 gene expression.
Methods For Treating Acute Acoustic Trauma
US Patent:
8420595, Apr 16, 2013
Filed:
Jul 25, 2007
Appl. No.:
12/374970
Inventors:
Richard Dana Kopke - Oklahoma City OK, US
Robert A. Floyd - Oklahoma City OK, US
Robert A. Floyd - Oklahoma City OK, US
Assignee:
Oklahoma Medical Research Foundation - Oklahoma City OK
International Classification:
A61K 38/06, A61K 31/15, A61K 31/195, A61K 38/00, A61K 31/41, A61P 27/16
US Classification:
514 23, 514359, 514563, 514640
Abstract:
The current invention provides methods and compositions for treating sensorineural hearing loss including but not limited to acute acoustic trauma (AAT). The composition includes compounds which function as free radical traps such as phenyl butyl nitrone (PBN), free radical scavengers, such as edaravone, resveratrol, ebselen and iron chelator and compounds from the family of antioxidant compounds including, but not limited to, N-acetylcysteine (NAC), Acetyl-L-Carnitine (ALCAR), glutathione monoethylester, ebselen, D-methionine and carbamathione. The compositions of the current invention may be delivered by injections or orally.